{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:19:02Z","timestamp":1789586342449,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T00:00:00Z","timestamp":1323648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T00:00:00Z","timestamp":1323648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/cmi.2011.53","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T04:41:02Z","timestamp":1323664862000},"page":"296-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":159,"title":["Liver fibrosis: mechanisms of immune-mediated liver injury"],"prefix":"10.1038","volume":"9","author":[{"given":"Ruonan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,12]]},"reference":[{"key":"BFcmi201153_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jhep.2004.04.003","volume":"40","author":"C Balabaud","year":"2004","unstructured":"Balabaud C, Bioulac-Sage P, Desmouliere A . The role of hepatic stellate cells in liver regeneration. J Hepatol 2004; 40: 1023\u20131026.","journal-title":"J Hepatol"},{"key":"BFcmi201153_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2010","unstructured":"Hernandez-Gea V, Friedman SL . Pathogenesis of liver fibrosis. Annu Rev Pathol 2010; 6: 425\u2013456.","journal-title":"Annu Rev Pathol"},{"key":"BFcmi201153_CR3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/hep.21176","volume":"43","author":"A Sangiovanni","year":"2006","unstructured":"Sangiovanni A, Prati GM, Fasani P . The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 2006; 43: 1303\u20131310.","journal-title":"Hepatology"},{"key":"BFcmi201153_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","volume":"112","author":"G Fattovich","year":"1997","unstructured":"Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up of 384 patients. Gastroenterology 1997; 112: 463\u2013472.","journal-title":"Gastroenterology"},{"key":"BFcmi201153_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jhep.2004.03.007","volume":"40","author":"VJ Desmet","year":"2004","unstructured":"Desmet VJ, Roskams T . Cirrhosis reversal: a duel between dogma and myth. J Hepatol 2004; 40: 860\u2013867.","journal-title":"J Hepatol"},{"key":"BFcmi201153_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1172\/JCI1018","volume":"102","author":"JP Iredale","year":"1998","unstructured":"Iredale JP . Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538\u2013549.","journal-title":"J Clin Invest"},{"key":"BFcmi201153_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1517\/14728222.8.5.423","volume":"8","author":"JA Fallowfield","year":"2004","unstructured":"Fallowfield JA, Iredale JP . Targeted treatments for cirrhosis. Expert Opin Ther Targets 2004; 8: 423\u2013435.","journal-title":"Expert Opin Ther Targets"},{"key":"BFcmi201153_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0076-6879(90)90009-P","volume":"190","author":"R Blomhoff","year":"1990","unstructured":"Blomhoff R, Berg T . Isolation and cultivation of rat liver stellate cells. Methods Enzymol 1990; 190: 58\u201371.","journal-title":"Methods Enzymol"},{"key":"BFcmi201153_CR9","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","volume":"275","author":"SL Friedman","year":"2000","unstructured":"Friedman SL . Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247\u20132250.","journal-title":"J Biol Chem"},{"key":"BFcmi201153_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2184.2004.00297.x","volume":"37","author":"MR Alison","year":"2004","unstructured":"Alison MR, Vig P, Russo F, Bigger BW, Amofah E, Themis M et al. Hepatic stem cells: from inside and outside the liver? Cell Prolif 2004; 37: 1\u201321.","journal-title":"Cell Prolif"},{"key":"BFcmi201153_CR11","first-page":"257","volume":"295","author":"K Wake","year":"1989","unstructured":"Wake K . Three-dimensional structure of the sinusoidal wall in the liver: a Golgi study. Prog Clin Biol Res 1989; 295: 257\u2013262.","journal-title":"Prog Clin Biol Res"},{"key":"BFcmi201153_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","volume":"10","author":"AM Gressner","year":"2006","unstructured":"Gressner AM, Weiskirchen R . Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006; 10: 76\u201399.","journal-title":"J Cell Mol Med"},{"key":"BFcmi201153_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA . Liver fibrosis. J Clin Invest 2005; 115: 209\u2013218.","journal-title":"J Clin Invest"},{"key":"BFcmi201153_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0168-8278(01)00260-4","volume":"36","author":"D Cassiman","year":"2002","unstructured":"Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T . Hepatic stellate cell\/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002; 36: 200\u2013209.","journal-title":"J Hepatol"},{"key":"BFcmi201153_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/jhep.2001.25173a","volume":"34","author":"GJ Gores","year":"2001","unstructured":"Gores GJ, Kaufmann SH . Is TRAIL hepatotoxic? Hepatology 2001; 34: 3\u20136.","journal-title":"Hepatology"},{"key":"BFcmi201153_CR16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1053\/gast.2002.35384","volume":"123","author":"R Fischer","year":"2002","unstructured":"Fischer R . Cariers A, Reinehr R, H\u00e4ussinger D. Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells. Gastroenterology 2002; 123: 845\u2013861.","journal-title":"Gastroenterology"},{"key":"BFcmi201153_CR17","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1053\/jhep.2003.50182","volume":"37","author":"YH Paik","year":"2003","unstructured":"Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA . Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide (LPS) in human hepatic stellate cells. Hepatology 2003; 37: 1043\u20131055.","journal-title":"Hepatology"},{"key":"BFcmi201153_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s10495-005-1055-4","volume":"10","author":"AM Elsharkawy","year":"2005","unstructured":"Elsharkawy AM, Oakley F, Mann DA . The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 2005; 10: 927\u2013939.","journal-title":"Apoptosis"},{"key":"BFcmi201153_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1172\/JCI1018","volume":"102","author":"JP Iredale","year":"1998","unstructured":"Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538\u2013549.","journal-title":"J Clin Invest"},{"key":"BFcmi201153_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea V, Friedman SL . Pathogenesis of liver fibrosis. Annu Rev Pathol 2011; 6: 425\u2013456.","journal-title":"Annu Rev Pathol"},{"key":"BFcmi201153_CR21","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1053\/j.gastro.2009.07.006","volume":"137","author":"R Higashiyama","year":"2009","unstructured":"Higashiyama R, Moro T, Nakao S, Mikami K, Fukumitsu H, Ueda Y et al. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology 2009; 137: 1459\u20131466.","journal-title":"Gastroenterology"},{"key":"BFcmi201153_CR22","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R, Neilson EG . Epithelial\u2013mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776\u20131784.","journal-title":"J Clin Invest"},{"key":"BFcmi201153_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-2001-17550","volume":"21","author":"A Geerts","year":"2001","unstructured":"Geerts A . History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 2001; 21: 311\u2013335.","journal-title":"Semin Liver Dis"},{"key":"BFcmi201153_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-2001-17556","volume":"21","author":"D Schuppan","year":"2011","unstructured":"Schuppan D, Ruehl M, Somasundaram R, Hahn EG . Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 2011; 21: 351\u2013372.2001;","journal-title":"Semin Liver Dis"},{"key":"BFcmi201153_CR25","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1074\/jbc.272.4.2446","volume":"272","author":"E Ohuchi","year":"1997","unstructured":"Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y . Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997; 272: 2446\u20132451.","journal-title":"J Biol Chem"},{"key":"BFcmi201153_CR26","doi-asserted-by":"publisher","first-page":"5872","DOI":"10.1074\/jbc.270.11.5872","volume":"270","author":"RT Aimes","year":"1995","unstructured":"Aimes RT, Quigley JP . Matrix metalloproteinase-2 is an interstitial collagenase\u2014inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3\/4- and 1\/4-length fragments. J Biol Chem 1995; 270: 5872\u20135876.","journal-title":"J Biol Chem"},{"key":"BFcmi201153_CR27","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1053\/gast.1996.v110.pm8608892","volume":"110","author":"RC Benyon","year":"1996","unstructured":"Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ . Expression of tissue inhibitor of metalloproteinases-1 and -2 is increased in fibrotic human liver. Gastroenterology 1996; 110: 821\u2013831.","journal-title":"Gastroenterology"},{"key":"BFcmi201153_CR28","doi-asserted-by":"crossref","unstructured":"Arthur MJ, Fibrosigenesis II . Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2000; 279: 4820\u20134828.","DOI":"10.1152\/ajpgi.2000.279.2.G245"},{"key":"BFcmi201153_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1055\/s-2001-17555","volume":"21","author":"JJ Maher","year":"2001","unstructured":"Maher JJ . Interactions between hepatic stellate cells and the immune system. Semi Liver Dis 2001; 21: 417\u2013426.","journal-title":"Semi Liver Dis"},{"key":"BFcmi201153_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1568-9972(02)00027-7","volume":"1","author":"TL McGaha","year":"2002","unstructured":"McGaha TL, Bona CA . Role of profibrogenic cytokines secreted by T cells in fibrotic processes in scleroderma. Autoimmun Rev 2002; 1: 174\u2013181.","journal-title":"Autoimmun Rev"},{"key":"BFcmi201153_CR31","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.cld.2008.07.006","volume":"12","author":"M Pinzani","year":"2008","unstructured":"Pinzani M, Vizzutti F . Fibrosis and cirrhosis reversibility: clinical features and implications. Clin Liver Dis 2008; 12: 901\u2013913.","journal-title":"Clin Liver Dis"},{"key":"BFcmi201153_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1386-6346(02)00136-5","volume":"24","author":"S Mahmood","year":"2002","unstructured":"Mahmood S, Sho M, Yasuhara Y, Kawanaka M, Niiyama G, Togawa K et al. Clinical significance of intrahepatic interleukin-8 in chronic hepatitis C patients. Hepatol Res 2002; 24: 413\u2013419.","journal-title":"Hepatol Res"},{"key":"BFcmi201153_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1053\/j.gastro.2004.10.005","volume":"128","author":"M Imamura","year":"2005","unstructured":"Imamura M, Ogawa T, Sasaguri Y, Chayama K, Ueno H . Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology 2005; 128: 138\u2013146.","journal-title":"Gastroenterology"},{"key":"BFcmi201153_CR34","doi-asserted-by":"publisher","first-page":"G949","DOI":"10.1152\/ajpgi.00215.2003","volume":"285","author":"RF Schwabe","year":"2003","unstructured":"Schwabe RF, Bataller R, Brenner DA . Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol 2003; 285: G949\u2013G958.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFcmi201153_CR35","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/hep.22500","volume":"48","author":"M Zeremski","year":"2008","unstructured":"Zeremski M, Petrovic LM, Chiriboga L, Brown QB, Yee HT, Kinkhabwala M et al. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 2008; 48: 1440\u20131450.","journal-title":"Hepatology"},{"key":"BFcmi201153_CR36","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/S0016-5085(03)01194-6","volume":"125","author":"A Bonacchi","year":"2003","unstructured":"Bonacchi A, Petrai I, Defranco RM, Lazzeri E, Annunziato F, Efsen E et al. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 2003; 125: 1060\u20131076.","journal-title":"Gastroenterology"},{"key":"BFcmi201153_CR37","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/hep.22890","volume":"49","author":"F Hong","year":"2009","unstructured":"Hong F, Tuyama A, Lee TF, Loke J, Agarwal R, Cheng X et al. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology 2009; 49: 2055\u20132067.","journal-title":"Hepatology"},{"key":"BFcmi201153_CR38","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki E, de Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007; 13: 1324\u20131332.","journal-title":"Nat Med"},{"key":"BFcmi201153_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hep.21695","volume":"46","author":"H Huang","year":"2007","unstructured":"Huang H, Shiffman ML, Friedman S, Venkatesh R, Bzowej N, Abar OT et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology 2007; 46: 297\u2013306.","journal-title":"Hepatology"},{"key":"BFcmi201153_CR40","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/hep.22697","volume":"49","author":"J Guo","year":"2009","unstructured":"Guo J, Loke J, Zheng F, Hong F, Yea S, Fukata M et al. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology 2009; 49: 960\u2013968.","journal-title":"Hepatology"},{"key":"BFcmi201153_CR41","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/hep.21867","volume":"46","author":"A Watanabe","year":"2007","unstructured":"Watanabe A, Hashmi A, Gomes DA, Town T, Badou A, Flavell RA et al. Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 2007; 46: 1509\u20131518.","journal-title":"Hepatology"},{"key":"BFcmi201153_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bbrc.2008.08.096","volume":"376","author":"E G\u00e4bele","year":"2008","unstructured":"G\u00e4bele E, M\u00fchlbauer M, Dorn C, Weiss TS, Froh M, Schnabl B et al. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. Biochem Biophys Res Commun 2008; 376: 271\u2013276.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcmi201153_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1172\/JCI200522675","volume":"115","author":"JS Duffield","year":"2005","unstructured":"Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S et al. Selective depletion of macrophages reveals distinct opposing roles during liver injury and repair. J Clin Invest 2005; 115: 56\u201365.","journal-title":"J Clin Invest"},{"key":"BFcmi201153_CR44","doi-asserted-by":"publisher","first-page":"G200","DOI":"10.1152\/ajpgi.2001.281.1.G200","volume":"281","author":"CA Rivera","year":"2002","unstructured":"Rivera CA, Bradford BU, Hunt KJ, Adachi Y, Schrum LW, Koop DR et al. Attenuation of CCl4-induced hepatic fibrosis by GdCl3 treatment or dietary glycine. Am J Physiol Gastrointest Liver Physiol 2002; 281: G200\u2013G207.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFcmi201153_CR45","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1172\/JCI36150","volume":"118","author":"SD Ricardo","year":"2008","unstructured":"Ricardo SD, van Goor H, Eddy AA . Macrophage diversity in renal injury and repair. J Clin Invest 2008; 118: 3522\u20133530.","journal-title":"J Clin Invest"},{"key":"BFcmi201153_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/jhep.2003.50002","volume":"37","author":"P Taimr","year":"2003","unstructured":"Taimr P, Higuchi H, Kocova E, Rippe RA, Friedman S, Gores GJ . Activated stellate cells express the TRAIL receptor-2\/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 2003; 37: 87\u201395.","journal-title":"Hepatology"},{"key":"BFcmi201153_CR47","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","volume":"134","author":"V Krizhanovsky","year":"2008","unstructured":"Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134: 657\u2013667.","journal-title":"Cell"},{"key":"BFcmi201153_CR48","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","volume":"130","author":"S Radaeva","year":"2006","unstructured":"Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B . Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis inducing ligand-dependent manners. Gastroenterology 2006; 130: 435\u2013452.","journal-title":"Gastroenterology"},{"key":"BFcmi201153_CR49","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20061287","volume":"204","author":"C Dunn","year":"2007","unstructured":"Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, Lampertico P et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007; 204: 667\u2013680.","journal-title":"J Exp Med"},{"key":"BFcmi201153_CR50","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/hep.21073","volume":"43","author":"C Morishima","year":"2006","unstructured":"Morishima C, Paschal DM, Wang CC, Yoshihara CS, Wood BL, Yeo AE et al. Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 2006; 43: 573\u2013580.","journal-title":"Hepatology"},{"key":"BFcmi201153_CR51","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.4049\/jimmunol.164.7.3862","volume":"164","author":"R Bonecchi","year":"2000","unstructured":"Bonecchi R, Facchetti F, Dusi S, Luini W, Lissandrini D, Simmelink M et al. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol 2000; 164: 3862\u20133869.","journal-title":"J Immunol"},{"key":"BFcmi201153_CR52","first-page":"3213","volume":"119","author":"MK Connolly","year":"2009","unstructured":"Connolly MK, Bedrosian AS, Mallen-St Clair J, Mitchell AP, Ibrahim J, Stroud A et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-\u03b1. J Clin Invest 2009; 119: 3213\u20133225.","journal-title":"J Clin Invest"},{"key":"BFcmi201153_CR53","first-page":"3417","volume":"117","author":"C de Lalla","year":"2004","unstructured":"de Lalla C, Galli G, Aldrighetti L, Romeo R, Mariani M, Monno A et al. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol 2004; 117: 3417\u20133425.","journal-title":"J Immunol"},{"key":"BFcmi201153_CR54","first-page":"3213","volume":"119","author":"MK Connolly","year":"2009","unstructured":"Connolly MK, Bedrosian AS, Mallen-St Clair J, Mitchell AP, Ibrahim J, Stroud A et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-\u03b1. J Clin Invest 2009; 119: 3213\u20133225.","journal-title":"J Clin Invest"},{"key":"BFcmi201153_CR55","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ng1599","volume":"37","author":"S Hillebrandt","year":"2005","unstructured":"Hillebrandt S, Wasmuth HE, Weiskirchen R, Hellerbrand C, Keppeler H, Werth A et al. Complement factor 5 is a quantitative trait gene that modifies liver. Nat Genet 2005; 37: 835\u2013843.","journal-title":"Nat Genet"},{"key":"BFcmi201153_CR56","first-page":"1165","volume":"19","author":"G Schlaf","year":"2004","unstructured":"Schlaf G, Schmitz M, Heine I, Demberg T, Schieferdecker HL, G\u00f6tze O . Upregulation of fibronectin but not of entactin, collagen IV and smooth muscle actin by anaphylatoxin C5a in rat hepatic stellate cells. Histol Histopathol 2004; 19: 1165\u20131174.","journal-title":"Histol Histopathol"},{"key":"BFcmi201153_CR57","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.4049\/jimmunol.166.4.2479","volume":"166","author":"D Mastellos","year":"2001","unstructured":"Mastellos D, Papadimitriou JC, Franchini S, Tsonis PA, Lambris JD . A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J Immunol 2001; 166: 2479\u20132486.","journal-title":"J Immunol"},{"key":"BFcmi201153_CR58","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/07853890600664608","volume":"38","author":"I Bykov","year":"2006","unstructured":"Bykov I, Junnikkala S, Pekna M, Lindros KO, Meri S . Complement C3 contributes to ethanol-induced liver steatosis in mice. Ann Med 2006; 38: 280\u2013286.","journal-title":"Ann Med"},{"key":"BFcmi201153_CR59","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/MCG.0b013e31820f7ee5","volume":"45","author":"MS Bugdaci","year":"2011","unstructured":"Bugdaci MS, Alkim C, Karaca C, Kesici B, Bayraktar B, Sokmen M . Could complement C4 be an alternative to biopsy for chronic hepatitis b histopathologic findings? J Clin Gastroenterol 2011; 45: 449\u2013455.","journal-title":"J Clin Gastroenterol"},{"key":"BFcmi201153_CR60","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4049\/jimmunol.153.2.753","volume":"153","author":"AW Cheever","year":"1994","unstructured":"Cheever AW, Williams ME, Wynn TA, Finkelman FD, Seder RA, Cox TM et al. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol 1994; 153: 753\u2013759.","journal-title":"J Immunol"},{"key":"BFcmi201153_CR61","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1172\/JCI7325","volume":"104","author":"MG Chiaramonte","year":"1999","unstructured":"Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA . An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 1999; 104: 777\u2013785.","journal-title":"J Clin Invest"},{"key":"BFcmi201153_CR62","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1172\/JCI24798","volume":"115","author":"TI Novobrantseva","year":"2005","unstructured":"Novobrantseva TI, Majeau GR, Amatucci A, Kogan S, Brenner I, Casola S et al. Attenuated liver fibrosis in the absence of B cells. J Clin Invest 2005; 115: 3072\u20133082.","journal-title":"J Clin Invest"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cmi201153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201153","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T05:25:34Z","timestamp":1672723534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi201153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,12]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFcmi201153"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2011.53","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,12]]},"assertion":[{"value":"26 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no financial or commercial conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}